Lupin launches generic Prucalopride tablets for chronic idiopathic constipation in the US market, a bioequivalent to Takeda's ...

Lupin receives USFDA approval for its generic version of Prucalopride tablets, used to treat chronic idiopathic constipation ...

Lupin launches Prucalopride tablets in US for chronic constipation treatment, bioequivalent to Motegrity, with estimated ...

Lupin has received USFDA approval for its ANDA for Prucalopride Tablets, used to treat Chronic Idiopathic Constipation in ...

Mumbai: Global pharma major Lupin Limited has launched Prucalopride Tablets, 1 mg, and 2 mg, in the United States, following ...

This product, bioequivalent to Motegrity Tablets of Takeda Pharmaceuticals, will be manufactured at Lupin's Goa facility in ...

Lupin receives FDA approval for Prucalopride Tablets to treat chronic idiopathic constipation, bioequivalent to Motegrity.

A study led by University of Manchester epidemiologists has revealed which opioid painkillers are most likely to be ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

With the weight-loss blockbuster drug Wegovy, now in India, renowned endocrinologist and diabetologist Dr. Ambrish Mithal ...

Lupin has launched Prucalopride tablets in the US following USFDA approval. The bowel disorder treatment enters a $184 ...

Mounjaro is a prescription drug used to help manage blood sugar levels in people with type 2 diabetes. It can cause constipation as a side effect. Learn about how to manage this side effect and more.